Meet the Directors
Kathy Partin, Ph.D.
Dr. Partin earned her undergraduate degree in history from the University of Michigan, and her doctorate in microbiology from the State University of New York at Stony Brook. She completed postdoctoral training at Duke University studying pathophysiology of HIV and the NIH National Institute of Child Health studying neurophysiology. Following her training, Dr. Partin joined the faculty of the Department of Biomedical Sciences at Colorado State University where she performed NIH-funded basic research on ionotropic glutamate receptor structure and function for nearly twenty years. In 2007, she was appointed to the position of Director of the Research Integrity & Compliance Review Office, overseeing IRB, IBC, IACUC, GxP research and the Responsible Conduct of Research program at CSU. She served as the Assistant to the Research Integrity Officer until 2013, when she was appointed as the CSU RIO and Vice President for Research, overseeing Laboratory Animal Resources and Export Control. Dr. Partin has taught RCR to undergraduate students, graduate students, postdoctoral fellows and faculty for many years, and has been active in the Association for Practical and Professional Ethics and the Association of Research Integrity Officers.
Director, Division of Investigative Oversight
Susan Garfinkel, Ph.D., joined ORI in 2003 as a Scientist-Investigator and is currently the Director for the Division of Investigative Oversight (DIO). Previously, she worked at the American Health Assistance Foundation where she served as Director of Research Grants. Prior to that she managed the Lung Cell and Vascular Biology Research Program at NHLBI, NIH; served as science advisor at the Einstein Institute for Science, Health and the Courts; served as Chair for the Public Education Committee of the International Society for Stem Cell Research; worked as an associate investigator at the Center for Molecular Medicine, Maine Medical Center Research Institute, and as a researcher in the Jerome H. Holland Laboratory, Department of Molecular Biology, American Red Cross. She received her doctorate in genetics from George Washington University and did postdoctoral training in the Holland Laboratory. She earned a bachelor’s degree in biology at SUNY-Binghamton.
Prior to joining ORI in 2014, Ms. Hammatt served as Director of the Research Integrity Program and as the Research Integrity Officer at the University of Hawaii. A licensed attorney with a Master's degree in Law and Ethics, Ms. Hammatt served on the faculty at the University of Hawaii medical and law schools and taught courses in biomedical ethics, regulatory compliance, human subjects protection, and responsible conduct of research. She also has served as the Legal and Regulatory Specialist and Chair of the Ethics and Regulatory Subcommittee for the NIH-funded Research Centers in Minority Institutions (RCMI) Translational Research Network (RTRN), a national consortium of 18 institutions dedicated to reducing health disparities through collaborative basic, clinical, and translational research. Among her many accomplishments, she led the harmonization of the IRB process across all 18 RCMI institutions. Ms. Hammatt has been a Fellow with the St. Francis International Center for Healthcare Ethics in Honolulu since 1997 and since 1995 has been involved in international projects to empower women in Central and East Europe as they develop initiatives that support their communities.
Ms. Hammatt received a B.A. in English Literature at Loyola Marymount University in Los Angeles, a Master's degree in Law and Ethics in Medicine from the University of Glasgow in Scotland, and a J.D. from the University of Hawaii, where she practiced law with Case Lombardi and Pettit, the oldest law firm in Hawaii.